Jeyanthi Ramanarayanan, “Advancements in Tyrosine Kinase Inhibitors Therapy: Role of Imatinib, the First Targeted Treatment for Chronic Myeloid Leukemia ”, MMRNP-V3, pp. 30–44, Aug. 2024.